Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hedron Analytical is a specialized contract research organization (CRO) that provides advanced analytical services to the biopharmaceutical industry, with a core focus on protein higher-order structure (HOS) analysis. The company is a leader in Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS), offering precise mapping of protein-protein and protein-ligand interactions. Their service portfolio includes epitope and paratope mapping, biosimilar comparability studies, and protein folding and stability analysis. By utilizing state-of-the-art mass spectrometry platforms, Hedron supports the development of complex biologics, including monoclonal antibodies and fusion proteins. The firm serves a global client base ranging from virtual biotechs to large pharmaceutical companies, helping them navigate structural characterization challenges during drug discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hedron Analytical.